VEGF165 attenuates the Th17/Treg imbalance that exists when transplanting allogeneic skeletal myoblasts to treat acute myocardial infarction
- 21 September 2012
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 62 (1) , 69-79
Abstract
Objectives To investigate whether Th17/Treg imbalance exists, and whether VEGF165 attenuates the imbalance in allogeneic skeletal myoblast transplantation (allo-SMT) for acute myocardial infarction (AMI). Methods On days 1, 2, 4, and 7 after allo-SMT, the percentages and ratios of Th17 and Treg cells were analyzed by flow cytometry in three groups—the AMI group, the AMI-S group (allo-SMT) and the AMI-V group (with VEGF165 treatment). Subsequently, related proinflammatory and regulatory cytokines and key transcription factors, ROR-γt mRNA and Foxp3 mRNA expression, were examined by Bio-plex and real-time polymerase chain reaction, respectively. Results On days 1, 2, 4, and 7, the percentage of Tregs, related cytokine concentrations and transcript factor Foxp3 mRNA in the AMI-S group were lower than those in the AMI group, while those in the AMI-V group were higher than those in the AMI group. However, the percentage of Th17 cells, related cytokine concentrations and ROR-γt mRNA in the AMI-S group were higher than those in the AMI group; those in the AMI-V group were lower than those in the AMI group. Compared with the AMI group, the ratios of Th17/Treg cells significantly increased in the AMI-S group and decreased in the AMI-V group. Conclusions Th17/Treg imbalance participated in the formation and development of the inflammatory and immune response after allo-SMT. However, transfected VEGF165 was able to relieve the severity of the Th17/Treg imbalance.Keywords
This publication has 49 references indexed in Scilit:
- RETRACTED: Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injuryInternational Journal of Cardiology, 2013
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?Immunity, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt functionNature, 2008
- The Foxp3+ regulatory T cell: a jack of all trades, master of regulationNature Immunology, 2008
- Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusionLife Sciences, 2008
- Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host diseaseBlood, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune diseaseClinical and Experimental Immunology, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006